Skip to main content
OpenTrials
Completed

NCT Number: NCT05935735

Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) in SUD Recovery

The goal of this clinical study is to learn whether treating sleep problems is helpful in people with substance abuse problems who are living in a residential treatment program. Another goal is to study whether treating sleep problems will help individuals stay in substance abuse recovery treatment for a greater amount of time.

Participants will be asked to complete surveys at the time of enrollment and every week for the next 9 weeks for a total of 8 times. Participants will be asked to wear a watch that measures sleep (sleep watch) while the participants are in the group and for a 2-week period after the participants complete the group. Participants may also be asked to participate in an interview about the experience with the group and wearing the watch. Participants will also have "homework" throughout a 4 week period. Homework is to complete a sleep diary each morning.

The first group of 50 participants will be enrolled in the brief behavioral treatment for insomnia (BBTI) group where the participants receive typical treatment plus the sleep intervention program. The investigators will use qualitative and quantitative data to identify implementation facilitators and barriers, then further modify BBTI to improve feasibility. After modifying the BBTI protocol and re-training staff, study procedures will remain intact with the exception that the investigators will double the recruitment and randomize participants to the modified BBTI (N=50) or standard-of-care (SOC) (N=50). All participants will complete all assessments except the SOC group will not complete treatment satisfaction surveys.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance Use Disorders Chemically-Induced Disorders Dyssomnias Insomnia Mental Disorders Nervous System Diseases Sleep Disorders, Intrinsic Sleep Initiation and Maintenance Disorders Sleep Wake Disorders Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cornerstone at Helping Up Mission Clinic

Baltimore, Maryland, 21203, United States

About this study

Brief behavioral treatment for insomnia (BBTI) is an efficacious evidence-based sleep intervention derived from cognitive behavioral therapy for insomnia (CBT-I) that may address barriers to widespread dissemination of insomnia therapy because it is brief (4 weeks), easily deliverable without need for specialty training (uses a hard-copy workbook) and behaviorally-focused. This proposal has the following two aims:

  • To use the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework, a well-established implementation framework that informs evaluation of health-related programs, including in community and substance use treatment settings, to evaluate the feasibility of implementing a modified BBTI among underserved special population of individuals in a residential recovery program;
  • To conduct a clinical trial to evaluate the efficacy of the modified BBTI on subjective and objective sleep outcomes compared with conventional standard-of-care. The end goal of this project is to provide empirical evidence of a modified BBTI's value in SUD recovery for individuals of diverse racial backgrounds. Successful completion of this study will promote the dissemination and sustainable adoption of an evidence-based, pragmatic, and accessible insomnia intervention in real-world SUD recovery programs.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • client of Cornerstone Clinic (CC); resident at Helping Up Mission (HUM)
  • active SUD
  • ≥ 18 years old
  • ISI ≥ 8
  • insomnia disorder as determined by Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Sleep Disorders (SIS-D)
  • able to understand English proficiently

Exclusion criteria

  • medical or psychiatric condition interfering with treatment or requiring hospitalization
  • inability to provide informed consent
  • declines behavioral health treatment at CC
  • suicidal ideation
  • acute alcohol withdrawal requiring medical attention
  • pregnant or breastfeeding
  • moderate-severe sleep apnea based on WatchPAT
  • restless legs syndrome based on SIS-D
  • discharged from HUM

Treatment and study plan

Brief Behavioral Therapy for Insomnia (BBTI)

Behavioral

4 in-person sessions; 1 individual and 3 group sessions

Primary outcomes

  1. Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) as Assessed by the Success Rate of Outreach

    Time frame: Up to 1 year

    The success rate of outreach is measured by:

    • Percent of eligible Helping Up Mission (HUM) residents who were referred to study
    • Percent of eligible HUM residents who consented to study
    • Percent of HUM residents who attended BBTI Session 1

    If overall score from the three parameters above is greater than 50%, outreach is feasible

  2. Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) as Assessed by the Success Rate of Adoption

    Time frame: Up to 1 year

    The success rate of adoption is measured by:

    • Provider satisfaction with training as assessed by semi-structured interviews with Cornerstone Clinic researchers and staff, HUM leadership, and providers
    • Provider satisfaction with facilitating BBTI as assessed by semi-structured interviews with participants

    If overall score from the parameters above is greater than 80%, adoption is feasible

  3. Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) as Assessed by the Success Rate of Treatment Integrity

    Time frame: Up to 1 year

    The success rate of treatment integrity is measured by percent of maintaining treatment based on fidelity checklist.

    If overall score is above 85% treatment integrity is feasible

  4. Changes in the Symptoms of Insomnia after Brief Behavioral Therapy for Insomnia (BBTI) as Measured by Insomnia Severity Index (ISI)

    Time frame: Baseline and post intervention up to 4 weeks

    Participants will complete ISI. Investigators will compare pre- and post-intervention primary outcomes. ISI is a 7-item questionnaire assessing the nature and symptoms of insomnia. ISI total score is the sum of all item scores which ranges from 0-28 and is interpreted as follows: no clinically significant insomnia (0-7), subthreshold insomnia (8-14), moderate clinical insomnia (15-21), and severe clinical insomnia (22-28). Negative changes in scores indicate improvement.

  5. Changes in Sleep Efficiency after Brief Behavioral Therapy for Insomnia (BBTI) as Measured by Actigraphy

    Time frame: Baseline and post intervention up to 4 weeks

    Participants in both arms will complete daily sleep diaries and wear an actiwatch. Sleep Efficiency is a measure of total sleep time over time in bed. Higher sleep efficiency indicates improved sleep.

  6. Changes in Substance Used Outcome as Measured by Treatment Retention [days]

    Time frame: Baseline and post intervention up to 4 weeks

    Treatment retention is number of days in substance used treatment. Treatment retention days will be counted by the number of days that the client is in treatment at the Helping Up Mission.

Secondary outcomes

  1. Treatment Satisfaction Rate as Assessed by Treatment Satisfaction Survey

    Time frame: 5 Weeks

    Participants will complete a treatment satisfaction survey at the end of each BBTI session. Response options are coded from 1 to 4. The total score ranges from 5 to 20 with a higher score indicating a greater satisfaction rate.

  2. Treatment Adherence Rate as Assessed by Treatment Adherence

    Time frame: 5 Weeks

    Treatment adherence is a measurement of BBTI sessions attended.

  3. Maintenance of Intervention

    Time frame: Up to 1 year

    Maintenance of intervention is a measurement of treatment availability over one year.

  4. Post-treatment Substance Use Disorder Relapse Rate as Assessed by Treatment Retention [days]

    Time frame: Up to 4 weeks post intervention

    Relapse Rate is percent of positive urine toxicology results. Treatment retention days will be counted by the number of days that the client is in treatment at the Helping Up Mission.

  5. Change in Quality of life as Measured by PROMIS Global Health Scale

    Time frame: Baseline and post intervention up to 4 weeks

    Participants will complete the PROMIS Global Health Scale post-intervention. This is a 10-item patient-reported questionnaire that assesses healthcare-related quality of life measures. The results of the questions are used to calculate two summary scores: a Global Physical Health Score and a Global Mental Health Score. The scores are standardized to the general population, using the "T-score" which is 50 points with a standard deviation of 10. Higher scores indicate better health.

  6. Change in Depression Measured by PROMIS Depression Scale

    Time frame: Baseline and post intervention up to 4 weeks

    Participants will complete PROMIS Depression Scale questionnaires at pre-treatment and post-treatment. This is a 4-item questionnaire that assesses depressed mood in the past 7 days. The total score ranges from 8 to 40 with higher scores indicating greater severity of depression. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.

  7. Change in Anxiety Measured by PROMIS Anxiety Scale

    Time frame: Baseline and post intervention up to 4 weeks

    Participants will complete the PROMIS Anxiety Scale questionnaires at pre-treatment and post-treatment. This is a 4-item questionnaire that assesses the severity of the individual's anxiety in the past 7 days. The total score ranges from 7 to 35 with higher scores indicating greater severity of anxiety. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.

  8. Change in Pain Measured by PROMIS Pain Interference Scale

    Time frame: Baseline and post intervention up to 4 weeks

    Participants will complete the PROMIS Pain Interference questionnaire at pre-treatment and post-treatment This is a 4-item questionnaire that assesses pain interference in the last 7 days. The total score ranges from 4 to 20 with higher scores indicating greater pain interference with daily activities. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.

  9. Change in Pain Measured by PROMIS Pain Severity Scale

    Time frame: Baseline and post intervention up to 4 weeks

    Participants will complete the PROMIS Pain Severity questionnaire at pre-treatment and post-treatment This is a 4-item questionnaire that assesses pain intensity in the past 7 days. The total score ranges from 3 to 9 with higher scores indicating severe pain. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.

Sponsors and collaborators

Lead sponsor

Johns Hopkins University

Other

Collaborators

  • American Academy of Sleep Medicine

Registry information

Official study title

Using Implementation Science to Examine the Feasibility and Efficacy of Brief Behavioral Therapy for Insomnia (BBTI) in Substance Use Disorder Recovery Programs

Acronym: BBTI_SUDs

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jul 7, 2023
Registry last updated
Apr 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.